Synthesis of (E)- and (Z)-[2-((Dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo-1-propenyl]bromobis(triphenylphosphine)palladium and the X-ray Crystal Structure Determination for the E-Isomer
摘要:
We report the preparation of (E)- and (Z)-[2-((dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo-1-propenyl]- bromobis(triphenylphosphine)palladium from the corresponding ethyl (E)- and(Z)-3-bromo-2[(dimethoxyphosphinyl)oxy]propenoate and the X-ray crystal structure determination for (E)-[2-((dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo- 1-propenyl]bromobis(triphenylphosphine)palladium. The (E)-palladium complex was reduced to (E)-3-[H-2]phosphoenolpyruvate by treatment with a mixture of trifluoroacetic acid-d/trifluoroacetic anhydride under strict anhydrous conditions. The H-1-NMR spectrum of the E-isomer obtained from the reduction of the palladium complex was identical to the H-1-NMR spectra of(E)-3-[H-2]phosphoenolpyruvate previously prepared by two different synthetic strategies. The X-ray structure of the palladium phosphoenolpyruvate analogue is the first X-ray structure of any 3-substituted phosphoenolpyruvate analogue reported and along with its synthesis and transformation interrelates the stereochemistry of several S-substituted phosphoenolpyruvate analogues.
Optimization of imidazole amide derivatives as cannabinoid-1 receptor antagonists for the treatment of obesity
作者:Roger A. Smith、Zahra Fathi、Furahi Achebe、Christiana Akuche、Su-Ellen Brown、Soongyu Choi、Jianmei Fan、Susan Jenkins、Harold C.E. Kluender、Anish Konkar、Rico Lavoie、Ronald Mays、Jennifer Natoli、Stephen J. O’Connor、Astrid A. Ortiz、Ning Su、Christy Taing、Susan Tomlinson、Theresa Tritto、Gan Wang、Stephan-Nicholas Wirtz、Wai Wong、Xiao-Fan Yang、Shihong Ying、Zhonghua Zhang
DOI:10.1016/j.bmcl.2007.03.011
日期:2007.5
Several imidazole-based cyclohexyl amides were identified as potent CB-1 antagonists, but they exhibited poor oral exposure in rodents. Incorporation of a hydroxyl moiety on the cyclohexyl ring provided a dramatic improvement in oral exposure, together with a ca. 10-fold decrease in potency. Further optimization provided the imidazole 2-hydroxy-cyclohexyl amide 45, which exhibited hCB-1 K-i = 3.7 nM and caused significant appetite suppression and robust, dose-dependent reduction of body weight gain in industry-standard rat models. (c) 2007 Elsevier Ltd. All rights reserved.
GORE, MAKARAND P.;NANJAPPAN, PALANIAPPAGOWNDER;HOOPS, GEOFFREY C.;WOODARD+, J. ORG. CHEM., 55,(1990) N, C. 758-760
Synthesis of (E)- and (Z)-[2-((Dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo-1-propenyl]bromobis(triphenylphosphine)palladium and the X-ray Crystal Structure Determination for the E-Isomer
作者:Garry D. Dotson、Jeffrey W. Kampf、Ronald W. Woodard
DOI:10.1021/jo00098a043
日期:1994.9
We report the preparation of (E)- and (Z)-[2-((dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo-1-propenyl]- bromobis(triphenylphosphine)palladium from the corresponding ethyl (E)- and(Z)-3-bromo-2[(dimethoxyphosphinyl)oxy]propenoate and the X-ray crystal structure determination for (E)-[2-((dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo- 1-propenyl]bromobis(triphenylphosphine)palladium. The (E)-palladium complex was reduced to (E)-3-[H-2]phosphoenolpyruvate by treatment with a mixture of trifluoroacetic acid-d/trifluoroacetic anhydride under strict anhydrous conditions. The H-1-NMR spectrum of the E-isomer obtained from the reduction of the palladium complex was identical to the H-1-NMR spectra of(E)-3-[H-2]phosphoenolpyruvate previously prepared by two different synthetic strategies. The X-ray structure of the palladium phosphoenolpyruvate analogue is the first X-ray structure of any 3-substituted phosphoenolpyruvate analogue reported and along with its synthesis and transformation interrelates the stereochemistry of several S-substituted phosphoenolpyruvate analogues.
Probing the Stereochemistry of <i>E. coli</i> 3-Deoxy-<scp>d</scp>-<i>arabino</i>-heptulosonate 7-Phosphate Synthase (Phenylalanine-Sensitive)-Catalyzed Synthesis of KDO 8-P Analogues
作者:Appavu K. Sundaram、Ronald W. Woodard
DOI:10.1021/jo991529l
日期:2000.9.1
The five-carbon phosphorylated monosaccharide analogues, D-arabinose 5-phosphate, D-ribose B-phosphate, and 2-deoxy-D-ribose 5-phosphate, were separately condensed with (Z)- and (E)-[3-H-2]-phosphoenolpyruvate (PEP) in the presence of Escherichia coli 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAH 7-P) synthase (phe) to give in the case of (Z)-[3-H-2]-PEP (3S)-[3-H-2]-3-deoxy-D-manno-octulosonate S-phosphate, (3S)-[3-H-2]-3-deoxy-D-altro-octulosonate 8-phosphate, and (3S)-[3-H-2]-3,5-dideoxy-D-altro-octulosonate 8-phosphate, respectively, whereas incubation with (E)-[3(2)H]-PEP gives the corresponding (3R)-monosaccharides. These results are in complete agreement with the observed facial selectivity of DAH 7-P synthase for its normal substrates D-erythrose 4-phosphate and PEP and provide direct evidence that DAH 7-P synthase (phe) catalyzes the si face addition of the C3 of PEP to the re face of C1 of the phosphorylated monosaccharides tested. Products formed by DAH 7-P synthase (phe)-catalyzed condensation of(Z)- and (E)-[3-F]-PEP with E 4-P were completely characterized by H-1 and F-19 NMR analysis for the first time. Results of our studies suggest that disappearence of the double bond between C2 and C3 of PEP and formation of a bond between C3 of PEP and C1 of the phosphorylated monosaccharide tested occur in concert during the DAH 7-P synthase-catalyzed condensation reaction.
Synthesis of (E)- and (Z)-3-deuteriophosphoenolpyruvate
作者:Makarand P. Gore、Palaniappagownder Nanjappan、Geoffrey C. Hoops、Ronald W. Woodard